Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Dec 17;19(1):362.
doi: 10.1186/s12882-018-1163-3.

A novel SLC12A3 homozygous c2039delG mutation in Gitelman syndrome with hypocalcemia

Wenjun Yang  1 , Shaoli Zhao  1 , Yanhong Xie  1 , Zhaohui Mo  2
Affiliations
Review

A novel SLC12A3 homozygous c2039delG mutation in Gitelman syndrome with hypocalcemia

Wenjun Yang et al. BMC Nephrol. .

Abstract

Background: Gitelman syndrome (GS) is a rare autosomal recessive renal tubular disease, caused by mutations in the SLC12A3 gene, which encodes the renal thiazide-sensitive Na/Cl cotransporter (NCCT) in the distal renal tubule.

Case presentation: A 23-year-old woman was admitted with limb numbness, recurrent tetany and palpitation. Laboratory tests showed hypokalemic alkalosis, hypomagnesemia, hypocalcemia and secondary hyperaldosteronism, as well as hypocalciuria and transient decreased PTH. Next-generation sequencing detected a novel homozygous mutations c.2039delG in the SLC12A3 gene, and her father and children were all heterozygous carriers.

Conclusion: We reported a case of GS with a novel homozygous frame-shift mutation of SLC12A3, and reviewed recent literatures about diagnosis, differential diagnosis and treatments. Hypocalcemia in Gitelman syndrome is rare, and may be related to inhibited PTH secretion induced by hypomagnesemia.

Keywords: Gitelman syndrome; Hypocalcemia; SLC12A3 gene mutation.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

No ethical approval was required for this case report. Written informed consent was obtained from all individual participants or the guardians (if under age of 18) included in the study.

Consent for publication

Written informed consent was obtained from all individuals who participated to publish the details in this case.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Pedigree analysis
Fig. 2
Fig. 2
Sequences of the patient, her children and her father. The above sequence column is the reference sequence, next are the sequence of the patient and her son, daughter, father, respectively. The columns below tested sequences are subtracted results of tested sequence and reference sequence, which show homozygous c.2039delG of the patient and heterozygous mutation of her children and father)
See this image and copyright information in PMC

References

    1. Gitelman HJ, Graham JB. Welt LG. A new familial disorder characterized by hypokalemia and hypomagnesemia. Trans Assoc Am Phys. 1966;79:221–235. - PubMed
    1. Mastroianni N, Bettinelli A, Bianchetti M, et al. Novel molecular variants of the Na-cl cotransporter gene are responsible for Gitelman syndrome. Am J Hum Genet. 1996;59(5):1019–1026. - PMC - PubMed
    1. Zhang L, Zhang J, Yang J, et al. PriVar: a toolkit for prioritizing SNVs and indels from next-generation sequencing data. Bioinformatics. 2013;29(1):124–125. - PubMed
    1. Parmar MS, Bhimji SS. Gitelman Syndrome. 2017.
    1. Blanchard A, Bockenhauer D, Bolignano D, et al. Gitelman syndrome: consensus and guidance from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int. 2017;91(1):24–33. - PubMed

Substances

LinkOut - more resources